AB&B BIO-TECH-B (02627) applies for full circulation of H shares.
Zhonghui Biotechnology-B (02627) announced that on October 15, 2025, the company has reached an agreement with the company's 816...
AB&B BIO-TECH-B (02627) announced that on October 15, 2025, the company has applied to the China Securities Regulatory Commission for the conversion of 81.662 million unlisted shares of the company into H shares and the listing of such shares on the Hong Kong Stock Exchange.
Related Articles
US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.
US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%
US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
US Stock Market Move | Popular Chinese concept stocks collectively rose sharply, with New Oriental Education & Technology Group, Inc. Sponsored ADR (EDU.US) jumping more than 8%.
US Stock Market Move | Gold stock continues to strengthen, Kinross Gold Corporation (KGC.US) rises more than 7%
US Stock Market Move | Omeros Corporation (OMER.US) soars 150% following asset purchase and license agreement with Novo Nordisk A/S Sponsored ADR Class B.
